Klabunde CN - Search Results

1

Emerging approaches to multiple chronic condition assessment.

Suls J, Salive ME, Koroukian SM, Alemi F, Silber JH, Kastenmüller G, Klabunde CN. Suls J, et al. Among authors: klabunde cn. J Am Geriatr Soc. 2022 Sep;70(9):2498-2507. doi: 10.1111/jgs.17914. Epub 2022 Jun 14. J Am Geriatr Soc. 2022. PMID: 35699153 Free PMC article.

2

National Institutes of Health Advancing Multimorbidity Research.

Salive ME, Suls J, Farhat T, Klabunde CN. Salive ME, et al. Among authors: klabunde cn. Med Care. 2021 Jul 1;59(7):622-624. doi: 10.1097/MLR.0000000000001565. Med Care. 2021. PMID: 33900269 Free PMC article.

3

Measuring Multimorbidity: Selecting the Right Instrument for the Purpose and the Data Source.

Suls J, Bayliss EA, Berry J, Bierman AS, Chrischilles EA, Farhat T, Fortin M, Koroukian SM, Quinones A, Silber JH, Ward BW, Wei M, Young-Hyman D, Klabunde CN. Suls J, et al. Among authors: klabunde cn. Med Care. 2021 Aug 1;59(8):743-756. doi: 10.1097/MLR.0000000000001566. Med Care. 2021. PMID: 33974576 Free PMC article.

4

Investment in Prevention Health Care Delivery Research by the National Institutes of Health.

Ganoza LF, Villani J, Klabunde CN. Ganoza LF, et al. Among authors: klabunde cn. Med Care. 2023 Feb 1;61(2):75-80. doi: 10.1097/MLR.0000000000001809. Epub 2022 Dec 6. Med Care. 2023. PMID: 36630558 Free PMC article.

5

Accuracy of Self-reported Colonic Polyps: Results from the Prostate, Lung, Colorectal, and Ovarian Screening Trial Study of Colonoscopy Utilization.

Wiseman KP, Silver MI, Klabunde CN, Buckman D, Wright P, Hickey TP, Schoen RE, Doria-Rose VP. Wiseman KP, et al. Among authors: klabunde cn. Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):982-989. doi: 10.1158/1055-9965.EPI-19-0951. Epub 2020 Feb 12. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32051194

6

Trends and black/white differences in treatment for nonmetastatic prostate cancer.

Klabunde CN, Potosky AL, Harlan LC, Kramer BS. Klabunde CN, et al. Med Care. 1998 Sep;36(9):1337-48. doi: 10.1097/00005650-199809000-00006. Med Care. 1998. PMID: 9749657

7

Assessing comorbidity using claims data: an overview.

Klabunde CN, Warren JL, Legler JM. Klabunde CN, et al. Med Care. 2002 Aug;40(8 Suppl):IV-26-35. doi: 10.1097/00005650-200208001-00004. Med Care. 2002. PMID: 12187165

8

Use of SEER-Medicare data for measuring cancer surgery.

Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Cooper GS, et al. Among authors: klabunde cn. Med Care. 2002 Aug;40(8 Suppl):IV-43-8. doi: 10.1097/00005650-200208001-00006. Med Care. 2002. PMID: 12187167

9

Utility of the SEER-Medicare data to identify chemotherapy use.

Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB. Warren JL, et al. Among authors: klabunde cn. Med Care. 2002 Aug;40(8 Suppl):IV-55-61. doi: 10.1097/01.MLR.0000020944.17670.D7. Med Care. 2002. PMID: 12187169

10

Measuring complications of cancer treatment using the SEER-Medicare data.

Potosky AL, Warren JL, Riedel ER, Klabunde CN, Earle CC, Begg CB. Potosky AL, et al. Among authors: klabunde cn. Med Care. 2002 Aug;40(8 Suppl):IV-62-8. doi: 10.1097/00005650-200208001-00009. Med Care. 2002. PMID: 12187170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page